Company news

GlucoTrack, Inc. news in 2025

GlucoTrack, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

December 30, 2025

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

November 13, 2025

Glucotrack, Inc. Encourages Shareholders to Vote

November 3, 2025

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

October 29, 2025

Glucotrack, Inc. Reminds Shareholders to Vote

October 28, 2025

Glucotrack to Participate in the Q3 Virtual Investor Summit

September 11, 2025

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

August 14, 2025

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

August 6, 2025

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

July 31, 2025

Glucotrack Announces Repurchase of Series A Warrants

July 8, 2025

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

June 25, 2025

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

June 12, 2025

Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management

June 9, 2025

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

June 4, 2025

Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives

May 28, 2025

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 28, 2025

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 20, 2025

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 14, 2025

First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients

May 13, 2025

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

May 13, 2025

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

April 16, 2025

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

April 3, 2025

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

March 31, 2025

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

March 19, 2025

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

March 18, 2025

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

February 26, 2025

Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

February 24, 2025

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

February 3, 2025

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

February 3, 2025

Glucotrack Announces Reverse Stock Split

January 29, 2025

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

January 28, 2025

Glucotrack Announces ISO 13485: 2016 Certification

January 20, 2025

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

January 14, 2025

Glucotrack to Present at TechBio Showcase™ 2025

January 6, 2025

Advancing Clinical Studies, Meeting Regulatory Milestones, Strengthening Its Strategic Framework And More: The Past Year For Glucotrack, And What Lies Ahead

January 6, 2025

Decks in 2025